title: A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia.
authors.affiliation: a Division of Oncology, Department of Medicine , Washington University School of Medicine , St. Louis , MO , USA.
authors.forename: Lukas D
authors.initials: LD
authors.lastname: Wartman
authors.affiliation: a Division of Oncology, Department of Medicine , Washington University School of Medicine , St. Louis , MO , USA.
authors.forename: Mark A
authors.initials: MA
authors.lastname: Fiala
authors.affiliation: a Division of Oncology, Department of Medicine , Washington University School of Medicine , St. Louis , MO , USA.
authors.forename: Theresa
authors.initials: T
authors.lastname: Fletcher
authors.affiliation: a Division of Oncology, Department of Medicine , Washington University School of Medicine , St. Louis , MO , USA.
authors.forename: Emily R
authors.initials: ER
authors.lastname: Hawkins
authors.affiliation: a Division of Oncology, Department of Medicine , Washington University School of Medicine , St. Louis , MO , USA.
authors.forename: Amanda
authors.initials: A
authors.lastname: Cashen
authors.affiliation: a Division of Oncology, Department of Medicine , Washington University School of Medicine , St. Louis , MO , USA.
authors.forename: John F
authors.initials: JF
authors.lastname: DiPersio
authors.affiliation: a Division of Oncology, Department of Medicine , Washington University School of Medicine , St. Louis , MO , USA.
authors.forename: Meagan A
authors.initials: MA
authors.lastname: Jacoby
authors.affiliation: a Division of Oncology, Department of Medicine , Washington University School of Medicine , St. Louis , MO , USA.
authors.forename: Keith E
authors.initials: KE
authors.lastname: Stockerl-Goldstein
authors.affiliation: a Division of Oncology, Department of Medicine , Washington University School of Medicine , St. Louis , MO , USA.
authors.forename: Iskra
authors.initials: I
authors.lastname: Pusic
authors.affiliation: a Division of Oncology, Department of Medicine , Washington University School of Medicine , St. Louis , MO , USA.
authors.forename: Geoffrey L
authors.initials: GL
authors.lastname: Uy
authors.affiliation: a Division of Oncology, Department of Medicine , Washington University School of Medicine , St. Louis , MO , USA.
authors.forename: Peter
authors.initials: P
authors.lastname: Westervelt
authors.affiliation: a Division of Oncology, Department of Medicine , Washington University School of Medicine , St. Louis , MO , USA.
authors.forename: Ravi
authors.initials: R
authors.lastname: Vij
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000473:pathology*; D009842:Oligopeptides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000473:pathology*; D061988:Proteasome Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012008:Recurrence; D019233:Retreatment; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D009842:Oligopeptides; D061988:Proteasome Inhibitors; C524865:carfilzomib